Polymorphonuclear neutrophils (PMNs) can contribute to the regulation of the host immune response by crosstalk with innate and adaptive leukocytes, including NK cells. Mechanisms by which this immunoregulation process occurs remain incompletely understood. Here, we focused on the effect of human neutrophil-derived serine proteases on NKp46, a crucial activating receptor expressed on NK cells. We used flow cytometry, Western blotting, and mass spectrometry (MS) analysis to reveal that cathepsin G [CG; and not elastase or proteinase 3 (PR3)] induces a time-and concentrationdependent, down-regulatory effect on NKp46 expression through a restricted proteolytic mechanism. We also used a functional assay to demonstrate that NKp46 cleavage by CG severely impairs NKp46-mediated responses of NK cells, including IFN-g production and cell degranulation. Importantly, sputa of cystic fibrosis (CF) patients, which have high concentrations of CG, also alter NKp46 on NK cells. Hence, we have identified a new immunoregulatory mechanism of neutrophils that proteolytically disarms NK cell responses.
Introduction
NK cells are innate immune lymphocytes that are mainly involved in controlling microbial infections and tumor development [1, 2] . NK cell effector functions include direct cytotoxicity and production of cytokines and chemokines involved in the shaping of immune responses. Human NK cells can be divided into 2 subsets-CD56 dim and CD56 bright -whose functional properties differ [3] . In the peripheral blood, most NK cells are CD56 dim CD16 + and have cytotoxic functions [4] . NK cells recognize infected and transformed cells using an elaborate array of-activating and inhibitory-cell-surface receptors that regulate their functional responses [5, 6] . One of the many activating receptors on NK cells is NKp46, which belongs to the family of the NCR. NKp46 (NCR1) is evolutionary conserved between mice and humans and is expressed on all NK cell subsets [7, 8] . This 46 kDa type 1 transmembrane glycoprotein has an intracellular tail, a transmembrane domain, and 2 extracellular Ig-like domains that are connected through a short peptide [9] . The few pathogen-associated ligands known to bind to NKp46 and activate NK cells include the hemagglutinins of influenza virus, Sendai viruses, and Newcastle disease virus [10, 11] . NKp46 also contributes to the clearance of Streptococcus pneumoniae [12] and Mycobacterium tuberculosis [13] . PMNs are another fundamental cellular component of the innate immune system. These phagocytic cells account for 50-70% of the leukocytes in the peripheral blood and are rapidly recruited to sites of infection. There, they capture and kill microorganisms by releasing soluble mediators, such as ROS, proteolytic enzymes, and antimicrobial peptides. PMNs also contribute to the regulation of host immune responses by producing cytokines and chemokines and by modulating the activities of several types of immune cells, including dendritic cells, macrophages, and T cells (for review, see ref. [14] ). The results of many studies suggest that neutrophil-derived proteases, such as elastase and CG, degrade soluble mediators and alter expression and function of cell-surface receptors. We [15, 16] and others [17] have demonstrated that elastase and CG deactivate receptors involved in host defense and inflammation, including the LPS coreceptor CD14 [15] , various proteaseactivated receptors [17] , and cytokine receptors [16] .
It is now becoming clear that PMNs also regulate NK cell function, maturation, and homeostasis in both humans and mice [18] [19] [20] . The results of the present study show that the serine protease CG, produced by activated PMNs, cleaves the NKp46-activating receptor on NK cells. This cleavage is specific, as the 2 other main PMN serine proteases (elastase and PR3) do not degrade NKp46. CG cleaves the extracellular Ig-like domains of NKp46, resulting in the loss of NKp46-mediated NK cell functions. We confirmed this cleavage with sputa from CF patients, as these fluids contain large amounts of both PMN and CG [21] . Hence, this report describes a new immunoregulatory proteolytic effect of neutrophils that can disarm the responses of NK cells at an inflammatory site.
MATERIALS AND METHODS

Cell isolation
Blood samples were collected from healthy volunteers from the Etablissement Francais du Sang (Cedex, France). Neutrophils were purified from EDTAwhole blood by negative magnetic selection using the EasySep Direct Human Neutrophil Isolation Kit (Stemcell Technologies, Cambridge, United Kingdom). Human blood NK cells were isolated from PBMC by negative magnetic selection using the NK Cell Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). CD3 Neutrophil activation, measurement, and inhibition of protease activities
Freshly isolated neutrophils were activated by incubation with 5 mM CaCl 2 (Sigma-Aldrich, St. Louis, MO, USA) and 0.5 mM fMLP (Sigma-Aldrich) for 15 min at 37°C. Proteolytic activities were measured using specific fluorescence resonance energy transfer substrates of human CG, HNE, and PR3 [22] . Proteases were inhibited by incubation for 30 min at room temperature with specific inhibitors. Extended Methods are available online.
Sputum processing
Biologic fluids were provided by adult patients with CF, Langerhans cell histiocytosis, or PB from the Pulmonology Department of the Teaching Hospital of Tours (France). This study was approved by the local Ethical Committee (#2007-R17) and was conducted in accordance with the ethical standards of the Helsinki Declaration.
NK cell treatment
NK cells (10 5 cells/100 ml) were incubated with PMN supernatants, purified human CG, or purified HNE (Preparatis, Krakow, Poland), with or without appropriate inhibitors, at 37°C for 45 min, except for kinetic studies.
Reactions were stopped with 1 mM a1ACT (Preparatis) to block CG or 1 mM EPI-hNE4 to block HNE. For the experiments with the sputum supernatants, NK cells were incubated for either 2 or 4 h.
Activation of NK cells by plate-bound mAb
NK cells were activated with mAb targeting CD16, NKG2D, 2B4, and NKp46 or mIgG1 isotype control (BD Biosciences, San Jose, CA, USA), as described previously [23] . Extended Methods are available online.
Cytotoxicity assay
K562 tumor cells were stained with calcein-AM (Thermo Fisher Scientific, Waltham, MA, USA) for determining the cytotoxic potential of NK cells using the calcein release assay, as described previously [24] . The fluorescence signal was measured using a Gemini spectrofluorometer (Molecular Devices, Sunnyvale, CA, USA).
Flow cytometry analysis
Flow cytometry analyses were performed using a MACSQuant analyzer (Miltenyi Biotec) and VenturiOne software (Applied Cytometry, Sheffield, United Kingdom). All of the antibodies used are available in the Supplemental Material. The gating strategies used are described in Supplemental Fig. 1 .
MS
The rhNKp46 domain (ab51221; Abcam, Cambridge, United Kingdom) was incubated with 0.1 mM purified CG in low-binding microcentrifuge tubes at 37°C. Sample solutions were analyzed directly by MS profiling using a MALDI-TOF/TOF Ultraflextreme (Bruker, Bremen, Germany) in positive reflector ion mode in the mass:charge ratio 500-3500 range and by nano-LC-tandem MS using an Ultimate 3000 Rapid Separation LC coupled to a Linear Trap Quadropole Orbitrap Velos (Thermo Fisher Scientific, Bremen, Germany), as described previously [25] .
Statistical analysis
All results are expressed as means 6 SEM. Statistical significance was determined using the Friedman test, Wilcoxon's signed-rank test, or the Kruskal-Wallis test, depending on the number of groups to be analyzed. Data were analyzed using GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). P , 0.05 were significant, as shown in figure legends.
RESULTS AND DISCUSSION
Activated neutrophils down-regulate NKp46 expression on NK cell surface
Large numbers of innate immune cells are recruited to inflammatory sites in injured tissues. The neutrophils recruited to these sites phagocytize pathogens, release active mediators, and communicate with other immune cells, including NK cells. The question we have addressed is whether neutrophils regulate the expression of critical receptors on NK cells during inflammation. Human blood-derived NK cells were first incubated for 45 min at 37°C with activated or resting neutrophils and were further stained with mAb directed against NKG2D, 2B4, CD16, CD56, DNAM-1, or NKp30. The expression of DNAM-1, 2B4, CD56, NKG2D, and CD16 was decreased, whereas NKp30 expression remained unchanged (data not illustrated). The underlying mechanisms may be complex, as they may involve proteolyticdependent and/or proteolytic-independent events. For the rest of the study, we essentially focused on the expression of NKp46, as it is considered as a pan-NK cell marker and also as it is critical in NK-mediated immune responses [8] . Flow cytometry studies showed that NKp46 is constitutively present on NK cells (see gating strategy in Supplemental Fig. 1 ), but its expression was dramatically decreased (by ;70%) when NK cells were coincubated with activated neutrophils (Fig. 1A and B).
(continued from previous page) PLCH = pulmonary Langerhans cell histiocytosis, PMN = polymorphonuclear neutrophil, PR3 = proteinase 3, PYDA = Ac-PYDA P(O-C6H4-4-Cl)2 , rhNKp46 = recombinant extracellular domain of human NKp46, ROS = reactive oxygen species Neutrophils and NK cells interact using a range of mechanisms, including cell-to-cell contact and the production of soluble mediators [18] . To address this notion, we analyzed the effect of supernatants from activated neutrophils on the expression of NKp46 on NK cells. The intensity of NKp46-associated fluorescence was strongly impaired (by ;67%) under these conditions, whereas NKp46 signal was not modified by supernatants from resting neutrophils (Fig. 1C) . Activation of neutrophils leads to degranulation, resulting in the release of a broad range of soluble factors, including proteases, cytokines, ROS, and antimicrobial peptides. Three of these-the serine proteases CG, HNE, and PR3-can impair tissue integrity, as well as receptor expression [26] . Accordingly, we used the broad-spectrum inhibitor of serine proteases, a1Pi, that entirely prevents the disappearance of the receptor, demonstrating that these proteases are involved in the decrease of NKp46 on NK cells (Fig. 1C) . Other studies have also shown that NK cells are sensitive to neutrophil-derived ROS [27, 28] . Hence, we examined this relationship by treating PMNderived supernatants with catalase, a scavenger of hydrogen peroxide. The NKp46-associated fluorescence on NK cells remained decreased even after catalase treatment for 45 min (Fig. 1C) , indicating that hydrogen peroxide does not contribute to the decrease in NKp46 under our experimental conditions. Viability staining also indicated that there was no extensive death of NK cells (data not shown).
The relevance of these findings for human pathophysiology was further checked by analyzing the effect of sputa from CF patients on NKp46 expression. The chronic lung inflammation that occurs in CF results in the constant recruitment of PMN to the lungs, where they secrete large amounts of the 3 neutrophil serine proteases [21] . As expected, the sputa contained high numbers of neutrophils, and the concentrations of HNE and CG were also very high (above 0.1 mM; data not shown). The incubation of NK cells with the supernatants of sputa from CF patients for 4 h led to a significant decrease (by ;61%) of their NKp46 expression (Fig. 1D) . Interestingly, no decrease of NKp46 expression was observed when NK cells were incubated with respiratory samples collected from neutrophil-unrelated disease, such as PLCH and PB (Fig. 1D) . It is of note that we did not detect any CG activity in those pathologic fluids (data not shown). Altogether, these data emphasize that NK cell exposure with human neutrophils secreting specific serine proteases results in a major decrease of NKp46 expression.
Effect of human neutrophil-derived CG on NKp46 expression
To decipher how CG, HNE, and PR3 were individually implicated in the decrease of NKp46 expression, purified NK cells were incubated with the supernatants of activated neutrophils that had been treated with highly specific inhibitors, such as a1ACT, which inhibits CG; EPI-hNE4, which inhibits HNE; and PYDA, which inhibits PR3 [26, 29, 30] . a1ACT significantly prevented the decrease of NKp46, whereas EPI-hNE4 and PYDA did not ( Fig. 2A) , suggesting that CG has a prominent role in this process. We also measured the concentrations of CG, HNE, and PR3 in these supernatants and found an inverse correlation between the concentration of active CG and the expression of NKp46 on NK cells (Supplemental Fig. 2 ). The specificity of the effect of CG on the decrease in NKp46 was confirmed by incubating NK cells with purified human CG for 45 min. Incubation with CG resulted in a significant concentration-dependent decrease in NKp46 expression, reaching 30% of the control values at 0.1 mM (Fig. 2B) . a1ACT totally inhibited this effect (Fig. 2B) . In accordance with the results obtained with EPI-hNE4 ( Fig. 2A) , the incubation of NK cells with 0.1 mM HNE for 45 min did not decrease the expression of NKp46 (Fig. 2B) . Interestingly, the concentrations of active CG measured in the supernatants of activated neutrophils and in CF sputa were both ;0.1 mM (Supplemental Fig. 2) . Next, we attempted to examine the effect of purified PR3 on NKp46, but the reconstitution buffer was highly toxic for NK cells. However, as we had demonstrated that CG is essential for reducing the expression of NKp46, we decided to focus the rest of our study on the action of 0.1 mM CG. Kinetic studies (Fig. 2C) showed that the level of expression of NKp46 on NK cells was 65% of controls after incubation with CG for 5 min and 30% after incubation for 40 min. The concentration of CG used (0.1 mM) had no cytotoxic effect on NK cells, as determined by flow cytometry and cell viability staining (data not shown). Finally, we confirmed that CG cleaved NKp46 in both subsets of human blood NK cells. We sorted CD56 dim and CD56 bright NK cells, and both populations were incubated with purified CG for 45 min. The expression of NKp46 on both subsets of NK cells was decreased after CG exposure (Fig. 2D) .
Besides NKp46, the triggering of NK cell functions requires a combination of positive signals mediated by distinct activating receptors, including NKp30, NKG2D, 2B4, DNAM-1, or CD16 [23, 31] . Therefore, we studied the influence of CG per se on the expression of these latter receptors. The incubation of NK cells with 0.1 mM CG for 45 min led to a nonsignificant decrease in NKG2D and CD16 (Fig. 2E) , whereas the level of expression of the other receptors was not affected (Fig. 2E) . Interestingly, the level of NKp30 was unchanged, although it belongs to the NCRs, such as NKp46 and NKp44. These receptors are members of the Ig superfamily, but they differ in their extracellular portions: NKp30 and NKp44 each have a single domain, whereas NKp46 has 2 [32] . We did not test the effect of CG on NKp44, as this receptor is only expressed on activated NK cells and was not detected under our experimental conditions. Altogether, these data highlight the importance of human neutrophilderived CG for the specific decrease of NKp46 on NK cells.
CG cleaves the extracellular region of NKp46
Our next experiments were designed to determine the mechanism of CG-dependent NKp46 down-regulation. NKp46 could be directly cleaved by CG or indirectly via an initial intracellular pathway triggered by CG that further resulted in the internalization or shedding of NKp46. We tested these possibilities using NK cells that had been fixed with 4% formaldehyde and unfixed control cells. We incubated those cells with CG and found that the amounts of NKp46 on the fixed and unfixed NK cells were similar (Fig. 3A) . This indicated that CG caused neither internalization nor shedding of NKp46 and suggested that it influenced the expression of NKp46 by direct proteolysis. To verify such an assumption, we initially aimed to evaluate by Western blotting the integrity of NKp46 endogenously expressed in NK cells. We failed, as none of the 4 anti-human NKp46 antibodies tested was specific and/or effective. Instead, rhNKp46 was incubated with 0.1 mM CG for various times, and the proteolysis products were assessed by SDS-PAGE. Intact, noncleaved rhNKp46 protein appeared as 1 major 26 kDa band (Fig. 3B) . After exposure to CG, a less-intense 26 kDa band was observed, as well as several fragments of ;23, 12, and 10 kDa (Fig. 3B) , indicating that CG does cleave the extracellular domain of NKp46. To confirm this result and identify the initial cleavage sites, rhNKp46 was incubated with CG for short times (30 s), and the mixture was further analyzed by MS. Two major peptides were observed, i.e., Y 121 DTPTLSVHPGPEVI 135 , located between the 2 extracellular Ig-like domains, and L 235 LTTETGLQKDHAL 248 , which is located near the transmembrane domain. These different sites are shown on a schematic representation of the ectodomain of NKp46 (Fig. 3C) and are rather consistent with the 2, ;12 and 10 kDa, cleavage fragments visible by SDS-PAGE. Altogether, we demonstrate that CG alters NKp46 by direct proteolysis.
Inhibition of NKp46-dependent NK cell function by CG
Lajoie et al. [23] recently showed that interaction of NKp46 with anti-NKp46-activating antibodies activates NK cells, in terms of degranulation, activation, and cytokine secretion, as assessed by CD107a expression, CD16 expression, and IFN-g secretion, respectively. We used this experimental system to evaluate the impact of NKp46 cleavage by CG. Thus, NK cells were incubated in plates coated with mAb targeting NKG2D and 2B4, associated with either anti-NKp46 or mIgG1 isotype antibodies. As a positive control, we also coated plates with anti-CD16-activating antibodies [33, 34] expression and NK cell functions (Supplemental Fig. 3 ). These results demonstrate that CG disarms NK cells by preventing their activity upon NKp46 engagement. To evaluate further the impact of CG on NK cell function, we examined NK cell cytolytic activity on the tumor K562 target cells. This study is of special interest, as this issue is controversial: some authors reported that CG promotes NK cell-dependent lysis of K562 [35] , whereas others did not [36] . Moreover, the implication of NKp46 in the recognition of K562 cells by NK cells is also disputed [37, 38] . In our hands, CG-treated NK cells did not significantly modify the lysis of K562 cells (Fig. 4D) , meaning that CG and NKp46 are likely not implicated in this cytotoxicity mechanism. In summary, we have established for the first time that human neutrophil-derived CG targets NKp46 on NK cells, causing defective activation of these cells. We have clearly demonstrated that CG has a direct, specific proteolytic action on the extracellular part of NKp46 on NK cells. This cleavage influences activation and degranulation and their capacity to produce IFN-g when NKp46 is stimulated with activating antibodies. These results point to a new regulatory pathway in innate immunity. The cleavage of NKp46 during the inflammatory process, in which neutrophils are strongly recruited and activated, may thus participate to make the organism more susceptible to subsequent NKp46-dependent infections. Specifically, this may contribute to the fact that defense mechanisms of patients with chronic lung diseases, such as chronic obstructive pulmonary disease and CF, are defective, despite the abundance of innate immune cells, such as neutrophils and NK cells [39, 40] . In that regard, we have demonstrated that sputa of CF patients, which have high concentrations of CG, cleave the NKp46 on NK cells. This could be one of the immune defects that participate to predispose CF patients to viral or bacterial infections and thus, to exacerbate the disease. K562 tumor cells were stained with calcein-AM and seeded in 96-well plates to generate maximum release (lysis with 1% Triton X-100), spontaneous release (lysis in medium), or lysis by NK cells at an E:T ratio of 2:1 (test release). After 4 h, the supernatant fluorescence was measured. The specific lysis was calculated using the formula [(test release2 spontaneous release)/(maximum release2 spontaneous release)] 3 100. Results are means 6 SEM of 6 separate experiments using NK cells from distinct donors. *P , 0.05 (Wilcoxon's test).
